Dean Maglaris is CEO and Chairman of the Board of Managers for Cytogel Pharma. Mr. Maglaris is a seasoned leader with more than 30 years in the pharmaceutical industry, joining Cytogel as its CEO in 2005. He has successfully guided the company through the identification of attractive compounds and the development of its lead compound, CYT-1010, which is entering Phase 2 clinical development, following a successful Phase 1 study in humans. Mr. Maglaris has long understood the need for a breakthrough solution to effectively and safely treat moderate to severe pain and has recognized the potential benefits CYT-1010 could provide to patients. As such, Cytogel has a clear priority on developing this new class of drugs and continually pursuing new intellectual property, which has resulted in several issued patents.
Understanding the benefits that critical drug development can have on patients, Mr. Maglaris held leadership positions at Pfizer ranging from general management, product and business development and marketing. His experience covers the spectrum of major therapeutic areas in pharmaceuticals as well as a wide array of medical device markets in the U.S. and worldwide. As Group Vice President and General Manager, he was instrumental in the development and launch of several products that became major successes, with several achieving annual sales in excess of $2.0 billion each. He attributes that success to focusing on discovering and developing drug solutions that actually address the needs of the patients and their providers, in a meaningful and comparatively better way.
Mr. Maglaris is active in the industry and has participated as a member of the Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization. He served as the Chair of the Board of Trustees of the University of Vermont, Chairman of the Board of Directors of the AmeriCares Foundation and an officer of the Board of Trustees of the New Canaan Country School in New Canaan, CT. He holds a B.S. degree from the University of Vermont and an MBA from Northeastern University.